Operating Profit Endring Dato
Adma Biologics USD -11941000 20.63M 2023-12
BioCryst Pharmaceuticals USD -11921000 37.8M 2023-09
Dynavax Technologies USD -8491000 13.61M 2023-12
Eli Lilly USD 2.39B 1.94B 2023-12
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Insmed USD -178272000 30.6M 2023-12
MannKind USD 7.86M 2.76M 2023-12
Merck USD -1933000000 7.68B 2023-12
Minerva Neurosciences USD -6079000 1.56M 2023-09
Novavax USD -125632000 181.09M 2023-09
Novo Nordisk DKK 26.91B 3.03B 2023-09
Peregrine Pharmaceuticals USD -11222000 9.06M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Xencor USD -35009000 16.74M 2023-12



MannKind Driftsresultatet - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.